adjuvant chemotherapy using tegafur ( 1- ( 2-tetra hydrofuryl ) -5-fluorouracil ) was given to 52 of 216 patients with recurrence risk of cervical cancer after primary surgical treatment , the degree of risk of recurrence having been formulated as a discriminant function by computer analysis of risk factors involved in disease recurrence .
C0016778
tegafur
C0016360
5-fluorouracil